TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT07136493

Circulating Tumor DNA Based Minimal Residual Disease Detection for Patients With Early-Stage Breast Cancer

Cause of deathFunding or business Automatic label, confidence 0.9, unverified. How labels are made.
“Funding This study has been closed at City of Hope at the request of the Sponsor due to delays and changes in study timeline.”

The sponsor’s own words in the registry.

Life of this trial

202520262027Registered2025-08-10Planned start2026-05-12 (planned)Withdrawn (as of)2026-06-25

Vital statistics

Status
Withdrawn
Phase
Na
Sponsor
City of Hope Medical Center
Sponsor type
University, hospital or other
Conditions
Anatomic Stage I Breast Cancer AJCC v8; Anatomic Stage II Breast Cancer AJCC v8; Anatomic Stage III Breast Cancer AJCC v8; Estrogen Receptor-Positive Breast Carcinoma; HER2-Negative Breast Carcinoma; HER2-Positive Breast Carcinoma
Interventions
Biospecimen Collection; Biospecimen Collection; Electronic Health Record Review; Survey Administration
Participants
0
Sites
5
Countries
United States

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.